Skip to main content
. Author manuscript; available in PMC: 2017 Oct 26.
Published in final edited form as: Adv Funct Mater. 2016 Sep 5;26(39):7057–7066. doi: 10.1002/adfm.201602808

Figure 9.

Figure 9

a) In vivo images and b) temporal trace of bioluminescence from GBM xenograft in an orthotopic mouse model intravenously injected with TPN-cur or F-127 (Control), and intraperitoneally with free curcumin in DMSO solution (b). Luciferin-induced tumor bioluminescence, reflecting the level of GBM proliferation, was imaged at the indicated time points with daily sample-treated mice (n = 3).